31 related articles for article (PubMed ID: 38534182)
1. Creation of a Métis-Specific Instrument for Cancer Screening: A Scoping Review of Cancer-Screening Programs and Instruments.
Letendre A; Khan M; Bartel R; Chiang B; James A; Shewchuk B; Kima J; Macphail M; Vaska M; Schwann M; Yang H; Kopciuk KA
Curr Oncol; 2023 Nov; 30(11):9849-9859. PubMed ID: 37999135
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and meta-analysis : diagnostic accuracy of faecal immunochemical testing for haemoglobin (FIT) in detecting colorectal cancer for both symptomatic and screening population.
Stonestreet J; Chandrapalan S; Woolley D; Uthman U; Arasaradnam RP
Acta Gastroenterol Belg; 2019; 82(2):291-299. PubMed ID: 31314191
[TBL] [Abstract][Full Text] [Related]
3. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy.
Collins MG; Teo E; Cole SR; Chan CY; McDonald SP; Russ GR; Young GP; Bampton PA; Coates PT
BMJ; 2012 Jul; 345():e4657. PubMed ID: 22833618
[TBL] [Abstract][Full Text] [Related]
4. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
[TBL] [Abstract][Full Text] [Related]
5. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
Pin Vieito N; Zarraquiños S; Cubiella J
World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
[TBL] [Abstract][Full Text] [Related]
6. Systematic scoping review: Use of the faecal immunochemical test residual buffer to enhance colorectal cancer screening.
McAuliffe T; Anderson JC; Larson RJ; Robertson DJ
Aliment Pharmacol Ther; 2024 May; 59(9):1033-1048. PubMed ID: 38534182
[TBL] [Abstract][Full Text] [Related]
7. Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.
Grobbee EJ; Wisse PHA; Schreuders EH; van Roon A; van Dam L; Zauber AG; Lansdorp-Vogelaar I; Bramer W; Berhane S; Deeks JJ; Steyerberg EW; van Leerdam ME; Spaander MC; Kuipers EJ
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009276. PubMed ID: 35665911
[TBL] [Abstract][Full Text] [Related]
8. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
9. Tests and investigations for colorectal cancer screening.
Carroll MR; Seaman HE; Halloran SP
Clin Biochem; 2014 Jul; 47(10-11):921-39. PubMed ID: 24769265
[TBL] [Abstract][Full Text] [Related]
10. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT).
Allison JE; Fraser CG; Halloran SP; Young GP
Gut Liver; 2014 Mar; 8(2):117-30. PubMed ID: 24672652
[TBL] [Abstract][Full Text] [Related]
11. Faecal immunochemical test outside colorectal cancer screening?
Pin-Vieito N; Puga M; Fernández-de-Castro D; Cubiella J
World J Gastroenterol; 2021 Oct; 27(38):6415-6429. PubMed ID: 34720531
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]